アメリカの持続的腎代替療法の市場規模は2028年までに9億5,720万米ドルに達すると予想されています。2021年から2028年にかけて6.1％のCAGRで拡大すると予想されています。アメリカ市場は、急性腎障害（AKI）のICU患者数の増加や敗血症の発生率の上昇により、成長が見込まれています。さらに、COVID-19が市場の成長にプラスの影響を与えています。さらに、国内には技術的に優れた機器の開発・商品化に注力している老舗の主要企業が存在し、政府が継続的腎代替療法の認知度を高めるための取り組みを行っていることも、予測期間中の市場成長を後押しすると考えられます。
重症患者のAKIに多く見られる体液過多は、CRRT装置の需要を高める重要な要因となっています。さらに、FDA（米国食品医薬品局）は、ICUでの高品質なCRRT装置の使用を推奨するために、メーカーに対して正確な法律を施行しています。これにより、近い将来、アメリカ市場に有利な成長機会がもたらされることが期待されます。
Baxter International, Inc.社、Fresenius Kabi社、Medtronic社などの大手企業は、研究開発に多額の投資を行い、技術的に高度なCRRT機器を開発しています。例えば、Baxter社は、PRISMAFLEXクリティカルケアシステムを開発しました。PRISMAFLEXは、患者の快適性と適合性に基づいて個別の治療を提供する多目的プラットフォームです。さらに、B. Braun社のDiapact CRRTシステムには、AKIや腎臓疾患の効果的な治療を可能にする最新技術が搭載されています。重要な血液ろ過のプロセスは、患者の回復を妨げることなく、正確に行われます。このようなCRRTシステムの進歩は、技術革新と相まってCRRTシステムの導入を促進し、近い将来、アメリカのCRRT市場の成長を後押しするものと期待されています。
目次
Table of Contents
Chapter 1 Research Methodology
1.1 Research Methodology
1.1.1 Information Procurement
1.2 Information or Data Analysis
1.3 Market Formulation & Validation
1.4 U.S. Market: CAGR Calculation
1.5 U.S. Based Segment Share Calculation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.2 Volume Price Analysis (Model 2)
1.7 List of Secondary Sources
Chapter 2 Objectives
2.1 Objective - 1:
2.2 Objective - 2:
2.3 Objective - 3:
2.4 Objective - 4:
Chapter 3 Executive Summary
3.1 Market Outlook
3.2 Segment Outlook
3.3 Competitive Insights
3.3.1 Market Segmentation
3.4 Market Snapshot
Chapter 4 Continuous Renal Replacement Therapy Market Variables, Trends & Scope
4.1 Market Lineage Outlook
4.1.1 Parent Market outlook
4.1.2 Ancillary Market
4.2 Penetration & Growth Prospect Mapping
4.3 Regulatory Framework
4.4 Pipeline Analysis
4.5 Market Dynamics
4.5.1 Market Driver Analysis
4.5.1.1 Increasing prevalence of Acute Kidney Injury (AKI) and associated chronic kidney disease
4.5.1.2 Rising geriatric population
4.5.1.3 Technological advancements in CRRT machines
4.5.1.4 Presence of a large number of hospitals & dialysis clinics and increasing healthcare expenditure
4.5.2 Market Restraint Analysis
4.5.2.2 Complications associated with usage of CRRT in critically ill neonates
4.5.3 Market Opportunity Analysis
4.5.3.1 Advancements in CRRT data management
4.5.4 Market Challenge Analysis
4.5.4.1 Availability of alternative therapies
4.6 Continuous Renal Replacement Therapy Market Analysis Tools
4.6.1 SWOT Analysis, By PEST
4.6.2 Porter’s Five Forces Analysis
4.7 Major Deals & Strategic Alliances Analysis
4.7.1 Geographical Expansion
4.7.2 Product Launches
4.8 COVID-19 Market Impact
4.8.1 Supply Chain
4.8.2 Changing Market Trends
Chapter 5 Continuous Renal Replacement Therapy Market: Segment Analysis, By Product, 2016 - 2028 (USD Million)
5.1 Definitions & Scope
5.2 Product Market Share Analysis, 2020 & 2028
5.3 Continuous Renal Replacement Therapy Market, By Product, 2015 to 2028
5.4 Market Size Forecasts And Trend Analysis
5.4.1 CRRT System
5.4.1.1 CRRT System Market, 2015 - 2028 (USD Million)
5.4.2 Disposables
5.4.2.1 Disposables Market, 2015 - 2028 (USD Million)
5.4.3 Liquids
5.4.3.1 Liquids Market, 2015 - 2028 (USD Million)
Chapter 6 Continuous Renal Replacement Therapy Market: Segment Analysis, By Modality, 2016 - 2028 (USD Million)
6.1 Definitions & Scope
6.2 Modality Market Share Analysis, 2020 & 2028
6.3 Continuous Renal Replacement Therapy Market, By Modality, 2016 to 2028
6.4 Market Size Forecasts And Trend Analysis
6.4.1 Slow Continuous Ultrafiltration (SCUF)
6.4.1.1 Slow Continuous Ultrafiltration (SCUF) Market, 2016 - 2028 (USD Million)
6.4.2 Continuous Venovenous Hemofiltration (CVVH)
6.4.2.1 Continuous Venovenous Hemofiltration (CVVH) Market, 2016 - 2028 (USD Million)
6.4.3 Continuous Venovenous Hemodialysis (CVVHD)
6.4.3.1 Continuous Venovenous Hemodialysis (CVVHD) Market, 2016 - 2028 (USD Million)
6.4.4 Continuous Venovenous Hemodiafiltration (CVVHDF)
6.4.4.1 Continuous Venovenous Hemodiafiltration (CVVHDF) market, 2016 - 2028 (USD Million)
Chapter 7 Continuous Renal Replacement Therapy Market: Competitive Analysis
7.1 Company Profiles
7.1.1 Baxter
7.1.1.1 Company overview
7.1.1.2 Financial performance
7.1.1.3 Product benchmarking
7.1.1.4 Strategic initiatives
7.1.2 B. Braun Melsungen AG
7.1.2.1 Company overview
7.1.2.2 Financial performance
7.1.2.3 Product benchmarking
7.1.2.4 Strategic initiatives
7.1.3 Fresenius Medical Care AG
7.1.3.1 Company overview
7.1.3.2 Financial performance
7.1.3.3 Product benchmarking
7.1.3.4 Strategic initiatives
7.1.4 Medtronic
7.1.4.1 Company overview
7.1.4.2 Financial performance
7.1.4.3 Product benchmarking
7.1.4.4 Strategic initiatives
7.1.5 Asahi Kasei Medical Co., Ltd.
7.1.5.1 Company overview
7.1.5.2 Financial performance
7.1.5.3 Product benchmarking
7.1.5.4 Strategic initiatives
7.1.6 Nipro Corporation
7.1.6.1 Company overview
7.1.6.2 Financial performance
7.1.6.3 Product benchmarking
7.1.6.4 Strategic initiatives
List of Tables
Table 1. U.S. continuous renal replacement therapy market, by product, 2016 - 2028 (USD Million)
Table 2. U.S. continuous renal replacement therapy market, by modality, 2016 - 2028 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain based sizing & forecasting
Fig. 6 QFD modelling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 U.S. continuous renal replacement therapy market segmentation
Fig. 9 Market summary (2020)
Fig. 10 Market lineage outlook
Fig. 11 Penetration & growth prospect mapping
Fig. 12 Regulatory framework
Fig. 13 Market driver relevance analysis (current & future impact)
Fig. 14 Market restraint relevance analysis (current & future impact)
Fig. 15 U.S. continuous renal replacement therapy market SWOT analysis
Fig. 16 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 17 Porter’s five forces analysis
Fig. 18 Continuous renal replacement therapy market: product movement analysis
Fig. 19 Continuous renal replacement therapy market product outlook: Key takeaways
Fig. 20 CRRT systems market, 2016 - 2028 (USD Million)
Fig. 21 Disposable’s market, 2016 - 2028 (USD Million)
Fig. 22 Liquid’s market, 2016 - 2028 (USD Million)
Fig. 23 Continuous renal replacement therapy market: modality movement analysis
Fig. 24 Continuous renal replacement therapy market modality outlook: Key takeaways
Fig. 25 Slow continuous ultra-filtration (SCUF) market, 2016 - 2028 (USD Million)
Fig. 26 Continuous venovenous hemofiltration (CVVH) market, 2016 - 2028 (USD Million)
Fig. 27 Continuous Venovenous Hemodialysis (CVVHD) market, 2016 - 2028 (USD Million)
Fig. 28 Continuous venovenous hemodiafiltration (CVVHDF) market, 2016 - 2028 (USD Million)
